Bionano Genomics
BNGO
Bionano Genomics (BNGO) news
Recent news
Bionano Genomics outlook FY revenue USD 31-33 million
AInvest Wire · Aug 10, 2026Bionano retires fully all senior secured convertible debentures
On May 28, 2026, Bionano Genomics, Inc. (Nasdaq: BNGO) announced the completion of a private placement of senior secured convertible debentures, which allowed the company to fully retire its previously issued convertible debt financing. The new financing, which raised $18.0 million in gross…
AInvest Wire · May 28, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.